Stocks and Investing Stocks and Investing
Mon, August 19, 2024
Fri, August 16, 2024

Yigal Nochomovitz Maintained (SNDX) at Strong Buy with Increased Target to $34 on, Aug 16th, 2024


Published on 2024-10-28 13:44:10 - WOPRAI, Yigal Nochomovitz
  Print publication without navigation


Yigal Nochomovitz of Citigroup, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Strong Buy with Increased Target from $30 to $34 on, Aug 16th, 2024.

Yigal has made no other calls on SNDX in the last 4 months.



There are 6 other peers that have a rating on SNDX. Out of the 6 peers that are also analyzing SNDX, 0 agree with Yigal's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Yigal


  • Edward White of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $45 on, Thursday, August 15th, 2024
  • Jason Zemansky of "B of A Securities" Maintained at Strong Buy with Increased Target to $31 on, Thursday, August 15th, 2024
  • Peter Lawson of "Barclays" Maintained at Buy with Increased Target to $33 on, Thursday, August 15th, 2024
  • Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $33 on, Tuesday, August 6th, 2024
  • Kelly Shi of "Jefferies" Initiated at Strong Buy and Held Target at $37 on, Friday, June 28th, 2024
  • Bradley Canino of "Stifel" Maintained at Strong Buy with Increased Target to $42 on, Wednesday, June 26th, 2024

Contributing Sources